NUWE — Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ
- Employees: 38
- Website: https://www.nuwellis.com
Latest SEC filings for NUWE
- EFFECT — 2026-08-27
- 424B3 — 2026-08-26
- 8-K — 2026-08-26
- S-3 — 2026-08-18
- S-3 — 2026-08-18
- 8-K — 2026-08-13
- 10-Q — 2026-08-13
- 424B5 — 2026-08-03
- 8-K — 2026-08-03
- 424B5 — 2026-08-03
Latest NUWE news
- — Nuwellis, Inc. (NASDAQ:NUWE) Shares Shorted: Short Interest Up 339.6% in September (defenseworld.net)
- — Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System (globenewswire.com)
- — Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences (globenewswire.com)
Educational tool only — not investment advice.